- Home
- PFBC vs NEO Comparison
PFBC vs NEO Comparison
Compare PFBC & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PFBC | NEO |
|---|---|---|
| Founded | 1991 | 2001 |
| Country | United States | United States |
| Employees | 324 | N/A |
| Industry | Major Banks | Precision Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | PFBC | NEO |
|---|---|---|
| Price | $88.60 | $8.08 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $102.67 | $11.14 |
| AVG Volume (30 Days) | 83.9K | ★ 1.6M |
| Earning Date | 04-24-2026 | 04-28-2026 |
| Dividend Yield | ★ 3.67% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.94 | $10.63 |
| Revenue Next Year | $8.31 | $9.73 |
| P/E Ratio | $8.85 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $73.08 | $4.72 |
| 52 Week High | $103.05 | $13.74 |
Technical Indicators
Market Signals| Indicator | PFBC | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 47.26 | 28.68 |
| Support Level | $88.78 | $7.59 |
| Resistance Level | $93.52 | $8.89 |
| Average True Range (ATR) | 2.40 | 0.44 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 62.20 | 14.39 |
Price Performance
Historical ComparisonAbout PFBC Preferred Bank
Preferred Bank is a commercial bank located in California. Its products and services are divided into Personal Banking, Business Banking, and Commercial Banking, which include Checking accounts, Savings accounts, CDs, Loans and Credit, Electronic banking, and Treasury Management. It provides personalized deposit services, real estate finance, commercial loans, and trade finance credit facilities to small and mid-sized businesses and their owners, entrepreneurs, real estate developers and investors, professionals, and high-net-worth individuals.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.